| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |